UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Gastroenterology, 2015-03, Vol.148 (3), p.639-651.e28

2015

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.100-107.e1

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

Gastroenterology (New York, N.Y. 1943), 2014-03, Vol.146 (3), p.736-743.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses

Gastroenterology (New York, N.Y. 1943), 2021-08, Vol.161 (2), p.560-574.e11

2021

Link zum Volltext

Verfügbarkeit prüfen

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2018-11, Vol.155 (5), p.1463-1473.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

257 DISPARITIES IN OUTCOMES AMONG HOMELESS PATIENTS HOSPITALIZED WITH GASTROINTESTINAL BLEEDING: A PROPENSITY-MATCHED ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-59-S-59

2021

Link zum Volltext

Verfügbarkeit prüfen

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2018-10, Vol.155 (4), p.1140-1153

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

Gastroenterology (New York, N.Y. 1943), 2015-11, Vol.149 (6), p.1462-1470

2015

Link zum Volltext

Verfügbarkeit prüfen

TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.1764-1777.e7

2018

Link zum Volltext

Verfügbarkeit prüfen

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2016, Vol.150 (1), p.134-144.e10

2016

Link zum Volltext

Verfügbarkeit prüfen

New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection

Gastroenterology (New York, N.Y. 1943), 2013-12, Vol.145 (6), p.1280-1288.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2021-04, Vol.160 (5), p.1608-1619.e13

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2020-11, Vol.159 (5), p.1715-1730.e12

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa1919 SALMONELLA TYPHIMURIUM INFECTION DECREASES INTESTINAL ASCORBIC ACID UPTAKE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-480-S-480

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.1240-1248

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

Gastroenterology (New York, N.Y. 1943), 2018-10, Vol.155 (4), p.1120-1127.e4

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2014-04, Vol.146 (4), p.980-988.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Su1247 THE INTESTINAL STEM CELL PROLIFERATION ALTERATIONS IN THE ANIMAL MODEL OF SEPSIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-564-S-564

2023

Link zum Volltext

Verfügbarkeit prüfen

107 DELIVERY MODE IMPACTS BACTERIOPHAGES IN THE DEVELOPING GUT MICROBIOME

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-15-S-16

2023

Link zum Volltext

Verfügbarkeit prüfen

823: SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN-2 UPREGULATES ASCORBIC ACID UPTAKE VIA THE HUMAN SODIUMDEPENDENT VITAMIN C TRANSPORTER-1

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-204-S-204

2022

Link zum Volltext

Verfügbarkeit prüfen

1095 – Transmembrane Protein 237 (TMEM237) Interacts with Human Riboflavin Transporter-3 (HRFVT3) in Intestinal Epithelial Cells and Modulates Its Function and Stability

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-233-S-234

2019

Link zum Volltext

Verfügbarkeit prüfen

Tu1245 CD8 T CELLS MEDIATE THE EFFECT OF INTESTINAL CRYPT EPITHELIAL CELL APOPTOSIS ON THE INDUCTION OF NECROTIZING ENTEROCOLITIS-LIKE MUCOSAL INJURY IN NEONATAL MICE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1006-S-1006

2023

Link zum Volltext

Verfügbarkeit prüfen

978 Intestinal-Specific Knockout of the Riboflavin Transporter-3 (RFVT-3) Impairs Gut Riboflavin Uptake

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S199-S199

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 203

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGastroenterology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(196)

Publikationsform

Artikel
(203)

Sprache

Englisch
(203)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(203)
ScienceDirect Journals (5 years ago - present)
(203)
Single Journals
(203)
IngentaConnect Journals
(125)

Menü

Weitere Dienste

Einstellungen

SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

257 DISPARITIES IN OUTCOMES AMONG HOMELESS PATIENTS HOSPITALIZED WITH GASTROINTESTINAL BLEEDING: A PROPENSITY-MATCHED ANALYSIS

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection

The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis

Sa1919 SALMONELLA TYPHIMURIUM INFECTION DECREASES INTESTINAL ASCORBIC ACID UPTAKE

Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Su1247 THE INTESTINAL STEM CELL PROLIFERATION ALTERATIONS IN THE ANIMAL MODEL OF SEPSIS

107 DELIVERY MODE IMPACTS BACTERIOPHAGES IN THE DEVELOPING GUT MICROBIOME

823: SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN-2 UPREGULATES ASCORBIC ACID UPTAKE VIA THE HUMAN SODIUMDEPENDENT VITAMIN C TRANSPORTER-1

1095 – Transmembrane Protein 237 (TMEM237) Interacts with Human Riboflavin Transporter-3 (HRFVT3) in Intestinal Epithelial Cells and Modulates Its Function and Stability

Tu1245 CD8 T CELLS MEDIATE THE EFFECT OF INTESTINAL CRYPT EPITHELIAL CELL APOPTOSIS ON THE INDUCTION OF NECROTIZING ENTEROCOLITIS-LIKE MUCOSAL INJURY IN NEONATAL MICE

978 Intestinal-Specific Knockout of the Riboflavin Transporter-3 (RFVT-3) Impairs Gut Riboflavin Uptake

Aktive Filter

Suchergebnisse filtern